Where does OnPoint Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OnPoint Medical, Inc. ranks #10,717 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OnPoint Medical, Inc. hold?

OnPoint Medical, Inc. holds 29 US utility patents granted between 2018 and 2025, spanning 9 technology areas.

What is OnPoint Medical, Inc.'s Innovation Score?

OnPoint Medical, Inc. has an Innovation Score of 46.8 out of 100 (top 20% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does OnPoint Medical, Inc. focus on?

OnPoint Medical, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 29 patents. Grants appear in 9 CPC subclasses total.

Is OnPoint Medical, Inc.'s patent grant rate increasing or decreasing?

OnPoint Medical, Inc.'s recent grant velocity is +450% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for OnPoint Medical, Inc.'s patents?

OnPoint Medical, Inc.'s patents average 24.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OnPoint Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

OnPoint Medical, Inc.

USPTO PatentsView assignee record - 29 granted patents across 9 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Onpoint ranks #10,717 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 9 technology areas.

#10,717
of 49,997 US assignees by volume: Top 20%
by Innovation Score (46.8/100): 24.1
avg claims per patent: +450%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10717 · US Corporation #10,717 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,717/49,997
PHOTO-FINISH Occipital
CPC-NARROW A61B · 9 areas
INNOV-PAR 46.8/100
CLAIMS-DENSE 24.1 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +450% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Occipital, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Cygames · near

47
Devicor Medical… · near

47
dSPACE digital… · near

47
Impossible Foods · near

47
OnPoint Medical · this assignee

47
3D Lighting… · lowest

7

What this shows Onpoint's Innovation Score is 46.8/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Onpoint's grants concentrate

OnPoint Medical, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2018. By volume, Onpoint sits between Olatec Therapeutics, Inc. and Pctel, Inc..

Onpoint's three-year grant acceleration

OnPoint Medical, Inc. shows 15 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Olatec Therapeuti…

29
Osmose Utilities…

29
Occipital

29
Oldcastle Buildin…

29
Orionis Bioscienc…

29
Palo Alto Network…

29
PB

29
Pctel

29
Onpoint Medical ◀

29

What this shows OnPoint holds 29 patents at rank #10,717, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OnPoint

By rank, the assignees closest to #10,717 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in OnPoint's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for OnPoint, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Impossible Foods Inc. 47 Cygames, Inc. 47 dSPACE digital signal processing and control engineering GmbH 47 Devicor Medical Products, Inc. 47

Onpoint's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

OnPoint Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	3.4%
2019	3	10.3%
2020	4	13.8%
2021	3	10.3%
2022	4	13.8%
2023	4	13.8%
2024	7	24.1%
2025partial year	3	10.3%

Which technologies does OnPoint Medical, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 29

G02B - Optical Elements, Systems OR Apparatus 25

G06T - Image Data Processing OR Generation, IN General 23

G06F - Electric Digital Data Processing 22

H04N - Pictorial Communication, e.g. Television 18

G16Z - Information AND Communication Technology [ICT] Specially Adapted FOR Specific Application Fields, NOT Otherwise Provided FOR 18

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 2

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 2

G09G - Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#10,717

of 49,997 tracked assignees

Innovation Score

46.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

OnPoint Medical, Inc.'s patent record in context - here's where to go next.

OnPoint Medical, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #10,717 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OnPoint Medical, Inc. against Olatec Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.